
<http://bio2rdf.org/drugbank:DB00057> a <http://schema.org/Drug> ;
	<http://schema.org/name> "Satumomab Pendetide" ;
	<http://schema.org/description> "Tumor associated glycoprotein (TAG) 72 (B72.3) monoclonal antibody conjugated with Indium 111 for radioimaging colon tumors. Satumomab Pendetide (trade name: OncoScint®) is no longer commercially available." ;
	<http://schema.org/drugClass> "Diagnostic Agents" ;
	<http://schema.org/url> "https://schemaorg.metadatacenter.org/drugbank/DB00057.html" ;
	<http://schema.org/clinicalPharmacology> "Binds to the tumor associated glycoprotein 72 antigen, which is a cell surface protein generally over-expressed in colorectal cancers. The radioactive Indium 111, which is covalently attached to the antibody, allows radiodiagnostic detection of TAG-72 expressing cells and tumors." ;
	<http://schema.org/legalStatus> "Withdrawn" , "Approved" ;
	<http://schema.org/mechanismOfAction> "Satumomab Pendetide is a monoclonal antibody which is attached to the chelator pentetic acid (DTPA) linked to the tripeptide  glycine  (G) – L-tyrosine (Y) – L-lysine (K), which chelates Indium 111. Satumomab pendetide binds selectively to cell-surface TAG-72 expressed on colorectal tumors." ;
	<http://schema.org/nonProprietaryName> "Indium-111 satumomab pendetide" , "Indium (111In) satumomab pendetide" ;
	<http://schema.org/proprietaryName> "OncoScint" ;
	<http://schema.org/identifier> "drugbank:DB00057" ;
	<http://schema.org/sameAs> <http://www.drugbank.ca/drugs/DB00057> .
